QurAlis logo

QurAlis jobs and careers

Cambridge, MA, United States

About QurAlis

QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.

Founded in 2016 by Clifford J Woolf, Kasper Roet and Kevin Eggan.

Founded
2016
Employees
11 to 50
Total funding
$135.5M
Headquarters
Cambridge

Leadership

The top of QurAlis's org chart, with how many people report into each leader.

KRPhoto of Kasper Roet

Kasper Roet

Founder, CEO

59 reports

DEPhoto of Daniel Elbaum

Daniel Elbaum

Chief Scientific Officer

30 reports

GI

Guzide Adhikari (Icke)

Vice President, Global Supply Chain

6 reports

VSPhoto of Vikas Sharma

Vikas Sharma

Chief Business Officer

5 reports

CTPhoto of Chris Thomajan

Chris Thomajan

Chief Financial Officer

3 reports

BFPhoto of Barry F.

Barry F.

Vice President, Quality Assurance (glp/gcp)

2 reports

HCPhoto of Hagen Cramer

Hagen Cramer

Chief Technology Officer

1 report

MB

Meredith Ball

Vice President, Human Resources

1 report

RWPhoto of Robin Wojcieszek

Robin Wojcieszek

Svp, Regulatory Affairs And Drug Safety

Board

CWPhoto of Clifford Woolf

Clifford Woolf

Scientific Advisor

KEPhoto of Kevin Eggan

Kevin Eggan

Scientific Advisor

MKPhoto of Matthew Kiernan

Matthew Kiernan

Scientific Advisor

MHPhoto of Michelle Hastings

Michelle Hastings

Scientific Advisor

JFPhoto of Johannes Fruehauf

Johannes Fruehauf

Director

MHPhoto of Michael Hutton

Michael Hutton

Director